Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Costa

Showing results (91-100 of 175) with videos related to

Pageof 18
Sort By:
Lung Cancer (Amsterdam, Netherlands)|September 6, 2017
De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinomaBrian J Carney, Deepa Rangachari, Paul A VanderLaan, et al.
JAMA Network Open|February 11, 2021
Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab MonotherapyKartik Sehgal, Ritu R Gill, Page Widick, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|February 9, 2021
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Journal of Thoracic Disease|January 10, 2018
Morphologic characteristics of pulmonary adenocarcinomas manifesting as pure ground-glass nodules on CTBenedikt H Heidinger, Kevin R Anderson, Ursula Nemec, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2006
C/EBP alpha mutations in lung cancerDaniel B Costa, Tajhal Dayaram, Francesco D'Alo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2010
Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinibStephanie Heon, Beow Y Yeap, Gregory J Britt, et al.
Academic Radiology|July 2, 2017
"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society GuidelinesBenedikt H Heidinger, Ursula Nemec, Kevin R Anderson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and SizeBenedikt H Heidinger, Kevin R Anderson, Ursula Nemec, et al.
Translational Lung Cancer Research|June 15, 2026
Lung cancer with <i>EGFR</i> PACC mutations: a practical review of available treatment options and novel therapies on the horizonJulia M Berg, Hollis Viray, Jenna Green, et al.
Pageof 18

Showing results (91-100 of 175) with videos related to

Sort By:
Pageof 18
Lung Cancer (Amsterdam, Netherlands)|September 6, 2017
De novo ERBB2 amplification causing intrinsic resistance to erlotinib in EGFR-L858R mutated TKI-naïve lung adenocarcinomaBrian J Carney, Deepa Rangachari, Paul A VanderLaan, et al.
JAMA Network Open|February 11, 2021
Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab MonotherapyKartik Sehgal, Ritu R Gill, Page Widick, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Time to SARS-CoV-2 Clearance Among Patients with Cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Cancer Medicine|February 9, 2021
Time to SARS-CoV-2 clearance among patients with cancer and COVID-19Wenxin Xu, Andrew J Piper-Vallillo, Poorva Bindal, et al.
Journal of Thoracic Disease|January 10, 2018
Morphologic characteristics of pulmonary adenocarcinomas manifesting as pure ground-glass nodules on CTBenedikt H Heidinger, Kevin R Anderson, Ursula Nemec, et al.
Lung Cancer (Amsterdam, Netherlands)|June 13, 2006
C/EBP alpha mutations in lung cancerDaniel B Costa, Tajhal Dayaram, Francesco D'Alo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 30, 2010
Development of central nervous system metastases in patients with advanced non-small cell lung cancer and somatic EGFR mutations treated with gefitinib or erlotinibStephanie Heon, Beow Y Yeap, Gregory J Britt, et al.
Academic Radiology|July 2, 2017
"Rounding" the Size of Pulmonary Nodules: Impact of Rounding Methods on Nodule Management, as Defined by the 2017 Fleischner Society GuidelinesBenedikt H Heidinger, Ursula Nemec, Kevin R Anderson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2017
Lung Adenocarcinoma Manifesting as Pure Ground-Glass Nodules: Correlating CT Size, Volume, Density, and Roundness with Histopathologic Invasion and SizeBenedikt H Heidinger, Kevin R Anderson, Ursula Nemec, et al.
Translational Lung Cancer Research|June 15, 2026
Lung cancer with <i>EGFR</i> PACC mutations: a practical review of available treatment options and novel therapies on the horizonJulia M Berg, Hollis Viray, Jenna Green, et al.
Pageof 18